Business Wire

OH-PROCTER-&-GAMBLE

14.5.2024 14:01:28 CEST | Business Wire | Press release

Share
P&G unveils plans to prominently feature superior performing brands during the Olympic and Paralympic Games Paris 2024

Procter & Gamble (NYSE: PG), a Worldwide Olympic and Paralympic Partner, announced plans today to prominently feature superior performing household and personal care brands during the Olympic and Paralympic Games Paris 2024 including Olympic-inspired brand marketing and in-store campaigns, brand-sponsored athlete partnerships, and complimentary products and services for athletes in the Athletes’ Village during Paris 2024.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240514255957/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

The Village Nursery with Pampers (Photo: Business Wire)

Before and during Paris 2024, more than 30 P&G brands will reach billions of engaged consumers in countries around the world through relevant ways that demonstrate product performance superiority. Inspired by the highest performance of the best athletes in the world, P&G’s household and personal care brands are launching Olympic and Paralympic Games-inspired marketing campaigns featuring the highest performance products that serve people every day, including:

  • Pampers empowers little champions on the move with Pampers® NEW Baby-Dry™ Pants, providing a superior fit and protection to win against leaks.
  • Ariel’s “Champion of Stain and Odor Removal” campaign is taking care of clothes on and off the field, even in cold and short washing machine cycles which are the toughest cleaning conditions.
  • Fairy’sTough Stain Cleaning Champion” campaign features its mascot, Mr. Fairy, and demonstrates superior product performance in automatic dishwashers, even in short cycles.
  • Venus is launching “The Power of Smooth” campaign to highlight Venus as the razor athletes trust to achieve smooth skin, especially in the last step in their pre-competition routine.
  • Gillette, a brand with a strong sports heritage, is bringing to life its long-standing promise of "the best a man can get" through a gold razor for Paris 2024 and a campaign featuring its highest performing Gillette Labs product line.
  • Always is the Official Period Product of Paris 2024. The “It's a New Period” campaign is aimed at addressing and eliminating period anxiety in the world of sports through the power of products with superior protection.
  • Head & Shoulders “Gold Medal Against Dandruff” features the “I Don’t” campaign, demonstrating how the brand prevents dandruff with an Olympic Games-themed twist.
  • Oral-B’s “Brush Like a Champion” campaign leverages the brand's role as the Official Oral Care Products of Paris 2024 to promote the use of Oral-B for cleaner, stronger teeth.
  • ZzzQuil’s “Sleep Like an Everyday Champion” campaign promotes better sleep as the key to performing at your best.

“Every day, P&G brands provide consumers with high performance products that they trust to meet their daily household and personal care needs for themselves and their families,” said P&G Chief Brand Officer Marc Pritchard. “That inspired us to prominently feature how those superior performing products serve athletes, families and fans so they can focus on achieving their personal best whether on the Olympic or Paralympic stage or in those everyday moments in life that matter.”

These P&G brand marketing campaigns and more will be supported by in-store and online retail activations across more than 150 retailers in more than 40 countries around the world. Over the last several Games, P&G and retailers have worked together to develop the Olympic and Paralympic Games into a highly relevant platform for engaging consumers to drive growth and value creation. The Games are particularly relevant in the host region and for Paris 2024, P&G brands are activating in retail stores across Europe behind the “Everyday Champions” campaign, providing products that give their best every day to meet the household and personal care needs of athletes, families, and fans – just like Olympians and Paralympians give their best to their sport.

During the Games, P&G brands will be providing more complimentary services and products to athletes than ever before, so they can focus on achieving their best when they step out on the world’s biggest stage. P&G brands will meet the everyday demands of more than 22,000 athletes and their staff within the Athletes’ Village, offering accessible and inclusive products and services, including:

  • The Village Nursery with Pampers: For the first time in the Olympic and Paralympic Games, Pampers® is creating a comfortable and convenient environment for athlete parents to connect with their babies and young children to enjoy precious moments together in the Athletes’ Village during Paris 2024. The nursery will provide a space for playtime and family bonding and cater to all babies and their diapering needs with Pampers highest quality diapers and wipes.
  • Beauty & Grooming Salon by Pantene®, Head & Shoulders®, Mielle®, Gillette® and Braun® will provide complimentary beauty and grooming treatments designed for all athletes to help them look and feel their best so they focus on giving their best when it matters most.
  • Laundry Rooms supplied by Ariel: Athletes will experience outstanding cleaning performance when they bring their clothes and uniforms to the laundry rooms for cold water washing laundry services supplied by Ariel, the Official Laundry Product of Paris 2024.
  • Dental Clinic with Oral-B® will give athletes the confidence of healthy smiles, offering athletes access to general and emergency dental services with high-performance Oral-B® toothbrushes, toothpastes and oral care education.
  • Period Protection: Always and Tampax® will provide period protection products in the restrooms throughout the Athletes’ Village.
  • P&G Everyday Champions Welcome Kit: Each athlete will receive a Paris-themed reusable bag equipped with P&G brand products such as Oral-B, Head & Shoulders, Aussie, Safeguard and Febreze to support their health and hygiene needs during Paris 2024.

“It’s incredible to see P&G brands recognize what matters most to athletes and show up for them during the Olympic and Paralympic Games in meaningful ways,” said Dame Laura Kenny, six-time Olympic medalist. “For athletes who are also juggling their role as a parent, connecting with their babies in an accessible space like the Village Nursery with Pampers will be an amazing resource, providing such valuable support to Olympic and Paralympic athletes during Games Time.”

P&G and P&G brands are also partnering with more than 100 of the world’s top-performing athletes, supporting their endeavors on and off the field of play in a variety of ways, through financial resources and even grant funding to their preferred charities through the Athletes for Good program. P&G’s full roster of athletes represents 17 countries and 37 sports and includes:

  • Two-time Olympic Gold Medalist Clarisse Agbegnenou, Judo, France, partnering with Pampers, Ariel, and Oral-B;
  • Olympic Gold Medalist Niek Kimmann, BMX, Netherlands, partnering with Gillette;
  • Three-time Paralympic Gold Medalist Marie-Amélie Le Fur, Para athletics, France, partnering with Always;
  • Paralympic Gold Medalist Alexis Hanquinquant, Para triathlon, France, partnering with Braun, Gillette, Head & Shoulders, and Oral-B;
  • Paralympic Gold Medalist Anastasia Pagonis, Para swimming, USA, partnering with Venus;
  • Two-time Olympic Medalist, Lydia Jacoby, Swimming, USA, partnering with Venus;
  • Olympic Gold Medalist Wang Shun, Swimming, China, partnering with Safeguard.

About P&G’s Olympic & Paralympic Games Program

P&G has been a Worldwide Partner of the International Olympic Committee (IOC) since 2010. In July 2020, P&G announced the extension of its worldwide partnership with the Olympic Games through the LA28 Games, including global rights with the International Paralympic Committee (IPC) and the Paralympic Games. Since becoming a Worldwide Partner of the Olympic Games, the Company and its brands including Always®, Tide®, Ariel®, Gillette® and Head & Shoulders® have partnered with more than 500 athletes to shine a light on their daily commitment to be the best they can be, just as P&G brands commit to delivering superior performance for people who count on the brands in their everyday lives.

About Procter & Gamble

P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit https://www.pg.com for the latest news and information about P&G and its brands. For other P&G news, visit us at https://www.pg.com/news.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240514255957/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release

If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids

Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release

Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use

DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release

-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating

HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release

HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi

Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release

Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye